Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Raboud

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
AIDS Patient Care and Stds|July 27, 2007
Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapyS Chihrin, T Antoniou, J Raboud, et al.
Annals of Internal Medicine|October 15, 1995
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study GroupJ S Montaner, M T Schechter, A Rachlis, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Comparison of three HIV antigen detection kits in sequential sera from a cohort of homosexual menS E Read, C J Major, R A Coates, et al.
Journal of Clinical Epidemiology|March 1, 1992
Using serial observations to identify predictors of progression to AIDS in the Toronto Sexual Contact StudyR A Coates, V T Farewell, J Raboud, et al.
HIV Medicine|December 6, 2013
Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapyP Ndumbi, J Gillis, J Raboud, et al.
AIDS (London, England)|October 29, 1998
Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected childrenU D Allen, S M King, M P Gomez, et al.
The Journal of Infectious Diseases|June 11, 2009
Mother-to-child transmission of GB virus C in a cohort of women coinfected with GB virus C and HIV in Bangkok, ThailandW Bhanich Supapol, R S Remis, J Raboud, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
HIV Medicine|November 10, 2010
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohortA M Cescon, C Cooper, K Chan, et al.
AIDS Research and Human Retroviruses|May 5, 1998
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiencyC M Tsoukas, J Raboud, N F Bernard, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
AIDS Patient Care and Stds|July 27, 2007
Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapyS Chihrin, T Antoniou, J Raboud, et al.
Annals of Internal Medicine|October 15, 1995
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study GroupJ S Montaner, M T Schechter, A Rachlis, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Comparison of three HIV antigen detection kits in sequential sera from a cohort of homosexual menS E Read, C J Major, R A Coates, et al.
Journal of Clinical Epidemiology|March 1, 1992
Using serial observations to identify predictors of progression to AIDS in the Toronto Sexual Contact StudyR A Coates, V T Farewell, J Raboud, et al.
HIV Medicine|December 6, 2013
Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapyP Ndumbi, J Gillis, J Raboud, et al.
AIDS (London, England)|October 29, 1998
Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected childrenU D Allen, S M King, M P Gomez, et al.
The Journal of Infectious Diseases|June 11, 2009
Mother-to-child transmission of GB virus C in a cohort of women coinfected with GB virus C and HIV in Bangkok, ThailandW Bhanich Supapol, R S Remis, J Raboud, et al.
HIV Clinical Trials|April 19, 2012
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapyJ Raboud, A Anema, D Su, et al.
HIV Medicine|November 10, 2010
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohortA M Cescon, C Cooper, K Chan, et al.
AIDS Research and Human Retroviruses|May 5, 1998
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiencyC M Tsoukas, J Raboud, N F Bernard, et al.
Pageof 5